Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Nature Reviews. Clinical Oncology|December 1, 2025
The development of CAR T cells for patients with CNS malignanciesZev A Binder, Stephen J Bagley, Jessica B Foster, et al.
Neurosurgery|July 28, 2021
Withdrawn as duplicate: Commentary: "Zooming in" on Glioblastoma: Understanding Tumor Heterogeneity and its Clinical Implications in the Era of Single-Cell Ribonucleic Acid SequencingAlfredo Lucas, James H Eberwine, Stephen J Bagley, et al.
Neuro-Oncology|March 7, 2018
CAR T-cell therapy for glioblastoma: recent clinical advances and future challengesStephen J Bagley, Arati S Desai, Gerald P Linette, et al.
Journal of Neuro-Oncology|October 25, 2018
RNA-seq for identification of therapeutically targetable determinants of immune activation in human glioblastomaStephen J Bagley, Wei-Ting Hwang, Steven Brem, et al.
Journal of Neurosurgery|November 7, 2025
Rate of biopsy prior to resection among patients with high-grade glioma: a nationwide database analysisSusanna D Howard, Tony Liu, Jesse Y Hsu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2019
Comparative Effectiveness of Carboplatin/Pemetrexed With Versus Without Bevacizumab for Advanced Nonsquamous Non-Small Cell Lung CancerStephen J Bagley, Suzanna Talento, Nandita Mitra, et al.
Neuro-Oncology Practice|September 16, 2024
No drug holidays in BRAF<sup>V600E</sup> glioma patients: An argument for dose reduction of targeted therapiesDanielle A Bazer, Anna Kolchinski, Nancy A O Bush, et al.
Frontiers in Oncology|October 14, 2024
The transformative potential of mRNA vaccines for glioblastoma and human cancer: technological advances and translation to clinical trialsIulia Tapescu, Peter J Madsen, Pedro R Lowenstein, et al.
Journal of Palliative Medicine|October 16, 2019
Top Ten Tips Palliative Care Clinicians Should Know When Caring for Patients with Brain CancerBenzi M Kluger, Douglas E Ney, Stephen J Bagley, et al.
Science Translational Medicine|February 15, 2023
Small-molecule toosendanin reverses macrophage-mediated immunosuppression to overcome glioblastoma resistance to immunotherapyFan Yang, Duo Zhang, Haowen Jiang, et al.
Pageof 9